Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi

Bharti Wadhwa, Vikas Malhotra, Sukhyanti Kerai, Farah Husain, Nalini Bala Pandey, Kirti N Saxena, Vinay Singh, Tom M Quinn, Feng Li, Erin Gaughan, Manu Shankar-Hari, Bethany Mills, Jean Antonelli, Annya Bruce, Keith Finlayson, Anne Moore, Kevin Dhaliwal, Christopher Edwards
doi: https://doi.org/10.1101/2022.07.01.22277163

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted July 02, 2022.
Download PDF
Data/Code
Email
Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi
Bharti Wadhwa, Vikas Malhotra, Sukhyanti Kerai, Farah Husain, Nalini Bala Pandey, Kirti N Saxena, Vinay Singh, Tom M Quinn, Feng Li, Erin Gaughan, Manu Shankar-Hari, Bethany Mills, Jean Antonelli, Annya Bruce, Keith Finlayson, Anne Moore, Kevin Dhaliwal, Christopher Edwards
medRxiv 2022.07.01.22277163; doi: https://doi.org/10.1101/2022.07.01.22277163
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area